FMR CORP 13D and 13G filings for Day One Biopharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-12 09:28 am Purchase |
2024-12-31 | 13G | Day One Biopharmaceuticals, Inc. DAWN |
FMR CORP | 12,887,467 12.800% |
1,600,140 (+14.18%) |
Filing |
| 2024-11-07 09:24 am Purchase |
2024-11-06 | 13G | Day One Biopharmaceuticals, Inc. DAWN |
FMR CORP | 11,287,327 11.192% |
3,874,947 (+52.28%) |
Filing |
| 2024-11-07 09:12 am Purchase |
2024-11-06 | 13G | Day One Biopharmaceuticals, Inc. DAWN |
FMR CORP | 7,412,380 7.539% |
3,444,214 (+86.80%) |
Filing |
| 2024-02-09 08:50 am Sale |
2024-02-08 | 13G | Day One Biopharmaceuticals, Inc. DAWN |
FMR CORP | 3,968,166 4.558% |
-2,050,892 (-34.07%) |
Filing |
| 2023-08-10 08:19 am Sale |
2023-08-09 | 13G | Day One Biopharmaceuticals, Inc. DAWN |
FMR CORP | 6,019,058 6.931% |
-2,983,252 (-33.14%) |
Filing |
| 2023-02-09 09:59 am Purchase |
2023-02-09 | 13G | Day One Biopharmaceuticals, Inc. DAWN |
FMR CORP | 9,002,310 12.239% |
693,136 (+8.34%) |
Filing |
| 2022-09-12 11:13 am Purchase |
2022-09-09 | 13G | Day One Biopharmaceuticals, Inc. DAWN |
FMR CORP | 8,309,174 11.310% |
8,309,174 (New Position) |
Filing |